Postoperative Radiotherapy Alone Versus Chemoradiotherapy in Stage I-II Endometrial Carcinoma: An Investigational and Propensity Score Matching Analysis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose The purpose of this study was to compare the results of postoperative adjuvant radiotherapy(RT) and concurrent chemoradiotherapy (CRT) in stage I-II endometrial carcinoma. Materials and MethodsWe analyzed a total of 64 patients with surgically staged I-II endometrial carcinoma whowere treated with postoperative adjuvant RT or concurrent CRT between March 1999 andJuly 2013. Thirty-two patients who received postoperative RT alone were matched withthose who received postoperative CRT (n=32) in accordance to age, stage, and tumorhistology. Overall survival and relapse-free survival, as well as toxicity of the RT and CRTarms were evaluated and compared. ResultsThe 5-year overall survival rate was 90.0% for the RT arm and 91.6% for the CRT arm. Therewas no significant difference in overall survival between the two treatment arms (p=0.798). The 5-year relapse-free survival rate was 87.2% in the RT arm and 88.0% in the CRT arm. Again, no significant difference in relapse-free survival was seen between the two arms(p=0.913). In a multivariate analysis, tumor histology was an independent prognostic factorfor relapse-free survival (hazard ratio, 3.67; 95% of CI, 2.34 to 7.65; p=0.045). Acute grade3 or 4 hematologic toxicities in the CRT arm were significantly higher than in the RT alonearm (6.2% vs. 31.2%, p=0.010). ConclusionAdjuvant pelvic concurrent chemoradioherapy did not show superior results in overallsurvival and relapse-free survival compared to RT alone in stage I-II endometrial carcinoma.
Abstract
Purpose The purpose of this study was to compare the results of postoperative adjuvant radiotherapy(RT) and concurrent chemoradiotherapy (CRT) in stage I-II endometrial carcinoma. Materials and MethodsWe analyzed a total of 64 patients with surgically staged I-II endometrial carcinoma whowere treated with postoperative adjuvant RT or concurrent CRT between March 1999 andJuly 2013. Thirty-two patients who received postoperative RT alone were matched withthose who received postoperative CRT (n=32) in accordance to age, stage, and tumorhistology. Overall survival and relapse-free survival, as well as toxicity of the RT and CRTarms were evaluated and compared. ResultsThe 5-year overall survival rate was 90.0% for the RT arm and 91.6% for the CRT arm. Therewas no significant difference in overall survival between the two treatment arms (p=0.798). The 5-year relapse-free survival rate was 87.2% in the RT arm and 88.0% in the CRT arm. Again, no significant difference in relapse-free survival was seen between the two arms(p=0.913). In a multivariate analysis, tumor histology was an independent prognostic factorfor relapse-free survival (hazard ratio, 3.67; 95% of CI, 2.34 to 7.65; p=0.045). Acute grade3 or 4 hematologic toxicities in the CRT arm were significantly higher than in the RT alonearm (6.2% vs. 31.2%, p=0.010). ConclusionAdjuvant pelvic concurrent chemoradioherapy did not show superior results in overallsurvival and relapse-free survival compared to RT alone in stage I-II endometrial carcinoma.
참고문헌 (25)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010", Cancer Research and Treatment, 45(1), pp.1~14 (2013), 대한암학회[DOI]
- Malzoni M, "Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for earlystage endometrial cancer : a prospective randomized study", Gynecol Oncol, 112, pp.126~133 (2009)
- Elshaikh MA, "Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma", Int J Radiat Oncol Biol Phys, 88, pp.351~356 (2014)
- ASTEC, "EN. 5 Study Group", Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis, 2009, pp.373, 137~146
- Creutzberg CL, "Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma", Lancet, 355, pp.1404~1411 (2000)
- Scholten AN, "Postoperative radiotherapy for Stage 1endometrial carcinoma : long-term outcome of the randomized PORTEC trial with central pathology review", Int J Radiat Oncol Biol Phys, 63, pp.834~838 (2005)
- Keys HM, "A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma : a Gynecologic Oncology Group study", Gynecol Oncol, 92, pp.744~751 (2004)
- Aalders J, "Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma : clinical and histopathologic study of 540 patients", Obstet Gynecol, 56, pp.419~427 (1980)
- Susumu N, "Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate-and high-risk endometrial cancer : a Japanese Gynecologic Oncology Group study", Gynecol Oncol, 108, pp.226~233 (2008)
- Maggi R, "Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma : results of a randomised trial", Br J Cancer, 95, pp.266~271 (2006)
- Randall ME, "Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma : a Gynecologic Oncology Group Study", J Clin Oncol, 24, pp.36~44 (2006)
- Mundt AJ, "Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone : implications for adjuvant radiation therapy", Int J Radiat Oncol Biol Phys, 50, pp.1145~1153 (2001)
- Creutzberg CL, "The role of radiotherapy in endometrial cancer : current evidence and trends", Curr Oncol Rep, 13, pp.472~478 (2011)
- Anderson JM, "High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer", Int J Radiat Oncol Biol Phys, 46, pp.417~425 (2000)
- Kuoppala T, "Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy", Gynecol Oncol, 110, pp.190~195 (2008)
- Klopp AH, "Node-positive adenocarcinoma of the endometrium : outcome and patterns of recurrence with and without external beam irradiation", Gynecol Oncol, 115, pp.6~11 (2009)
- Hogberg T, "Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer : results from two randomised studies", Eur J Cancer, 46, pp.2422~2431 (2010)
- "Randomized trial of radiation therapy with or without chemotherapy for endometrial cancer (PORTEC-3)" (2006)[URL]
- Morrow CP, "Relationship between surgicalpathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium : a Gynecologic Oncology Group study", Gynecol Oncol, 40, pp.55~65 (1991)
- Zaino RJ, "Pathologic models to predict outcome for women with endometrial adenocarcinoma : the importance of the distinction between surgical stage and clinical stage : a Gynecologic Oncology Group study", Cancer, 77, pp.1115~1121 (1996)
- Greven KM, "Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation?", Int J Radiat Oncol Biol Phys, 39, pp.413~418 (1997)
- Irwin C, "The role of adjuvant radiotherapy in carcinoma of the endometrium-results in 550 patients with pathologic stage I disease", Gynecol Oncol, 70, pp.247~254 (1998)
- Yalman D, "Postoperative radiotherapy in endometrial carcinoma : analysis of prognostic factors in 440 cases", Eur J Gynaecol Oncol, 21, pp.311~315 (2000)
- Yu M, "A comparison of dosimetric parameters between tomotherapy and three-dimensional conformal radiotherapy in rectal cancer", Radiat Oncol, 8, pp.181~ (2013)
- 유미나, "Dosimetric evaluation of Tomotherapy and four-box field conformal radiotherapy in locally advanced rectal cancer", Radiation oncology journal, 31(4), pp.252~259 (2013), 대한방사선종양학회